ArticleKidney medicine2026
Diagnostic Accuracy of Bone Turnover Markers in Patients With CKD: A Systematic Review and Meta-Analysis.
Article in Kidney medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rationale & Objective: Abnormal bone turnover in chronic kidney disease (CKD) increases fracture risk and influences treatment response, making accurate assessment essential. Although bone histomorphometry is the diagnostic gold standard, its invasiveness limits routine use. This study evaluated the diagnostic accuracy of noninvasive bone turnover markers-tartrate-resistant acid phosphatase 5b (TRAP5b), bone-specific alkaline phosphatase (BALP), and procollagen type I N-terminal propeptide (PINP)-compared with parathyroid hormone (PTH) for detecting high or low bone turnover in CKD. Study Design: A systematic review and meta-analysis of observational studies. Setting & Study Populations: Adult patients with CKD (all stages). Selection Criteria for Studies: Studies were included if they compared serum bone turnover markers to bone histomorphometry. Data Extraction: Two reviewers independently extracted study characteristics, population details, assay types, cutoff thresholds, sensitivity, specificity, and area under the ROC curve (AUC). Analytical Approach: A meta-analysis using random-effects models pooled AUCs for detecting high and low bone turnover per marker including intact PTH. Subgroup analyses assessed assay types (mass-based vs activity-based BALP, intact vs total PINP) and CKD stages. Results: Eight studies were included with 6 studies providing AUC data for pooling. Intact PINP and BALP (mass assay) demonstrated the highest accuracy for identifying high bone turnover, whereas intact PTH showed only moderate discriminatory performance. For low turnover, TRAP5b, BALP, and intact PINP displayed comparable accuracy, while total PINP and PTH were less reliable. Reported diagnostic thresholds varied but generally yielded sensitivities of 50%-90% and specificities of 60%-95%. One study suggested that combining bone turnover markers, such as PINP with BALP or TRAP5b, may further enhance diagnostic discrimination. Limitations: Limited representation of non-hemodialysis populations, small sample sizes, and lack of standardized methods to determine thresholds. Conclusions: TRAP5b, BALP, and intact PINP demonstrated moderate diagnostic accuracy and may support treatment decisions in CKD when bone biopsy is not feasible. (PROSPERO: CRD420251003120).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.